Clinical radioimmunotherapy of solid-tumors with chemically modified I-131 labeled chimeric TNT monoclonal antibodies.

被引：0
|
作者：
Jiang, C
Zhoang, G
Cesarman, G
Hu, P
Khawli, LA
Epstein, AL
机构：
[1] Shanghai Med Univ, Shanghai 200032, Peoples R China
[2] Natl Inst Nutr, Mexico City, DF, Mexico
[3] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1087
引用
收藏
页码：247P / 247P
页数：1
相关论文
共 50 条
  • [41] Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG
    Behr, TM
    Sharkey, RM
    Juweid, ME
    Dunn, RM
    Vagg, RC
    Ying, ZL
    Zhang, CH
    Swayne, LC
    Vardi, Y
    Siegel, JA
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (06) : 858 - 870
  • [42] Radioimmunotherapy of CEA-expressing cancers: Clinical results with an I-131-labeled anti-CEA monoclonal IgG(1)
    Behr, TM
    Sharkey, RM
    Juweid, ME
    Dunn, RM
    Vagg, RC
    Swayne, LC
    Siegel, JA
    Goldenberg, DM
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH, 1997, : 295 - 300
  • [43] CLINICAL-EXPERIENCE WITH RHENIUM-186-LABELED MONOCLONAL-ANTIBODIES FOR RADIOIMMUNOTHERAPY - RESULTS OF PHASE-I TRIALS
    BREITZ, HB
    WEIDEN, PL
    VANDERHEYDEN, JL
    APPELBAUM, JW
    BJORN, MJ
    FER, MF
    WOLF, SB
    RATLIFF, BA
    SEILER, CA
    FOISIE, DC
    FISHER, DR
    SCHROFF, RW
    FRITZBERG, AR
    ABRAMS, PG
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (06) : 1099 - 1112
  • [44] RADIOIMMUNODETECTION OF NECROTIC LESIONS IN HUMAN TUMORS USING I-131-LABELED TNT-1 F(AB)2 MONOCLONAL-ANTIBODY
    EPSTEIN, AL
    CHEN, D
    ANSARI, A
    NAJAFI, A
    SIEGEL, M
    LEE, K
    HU, E
    ROSEN, P
    WATKINS, K
    STAIN, S
    WEAVER, F
    TAYLOR, CR
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (02): : 151 - 161
  • [45] USE OF I-131 LABELED ANTI-IA MONOCLONAL-ANTIBODIES AS A PREPARATIVE REGIMEN PRIOR TO BONE-MARROW TRANSPLANTATION - INITIAL DOSIMETRY
    APPELBAUM, FR
    BADGER, C
    DEEG, HJ
    NELP, WB
    STORB, R
    CANCER DRUG DELIVERY, 1985, 2 (03): : 210 - 210
  • [46] LABELING OF MONOCLONAL-ANTIBODIES WITH A GA-67 PHENOLIC AMINOCARBOXYLIC ACID CHELATE .2. COMPARISON OF IMMUNOREACTIVITY AND BIODISTRIBUTION OF MONOCLONAL-ANTIBODIES LABELED WITH THE GA-67 CHELATE OR WITH I-131
    MATZKU, S
    SCHUHMACHER, J
    KIRCHGESSNER, H
    BRUGGEN, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (08): : 405 - 412
  • [47] COMPARISON OF PHASE-I TRIALS OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODIES (MABS) 528 AND 225 LABELED WITH I-131 AND IN-111
    SCOTT, AM
    BASELGA, J
    DIVGI, CR
    PFISTER, D
    KRIS, M
    ZHANG, JJ
    DAGHIGHIAN, F
    CARMICHAEL, N
    OETTGEN, HF
    LARSON, SM
    MENDELSOHN, J
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P213 - P213
  • [48] Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial
    Kraeber-Bodéré, F
    Rousseau, C
    Bodet-Milin, C
    Ferrer, L
    Faivre-Chauvet, A
    Campion, L
    Vuillez, JP
    Devillers, A
    Chang, CH
    Goldenberg, DM
    Chatal, JF
    Barbet, J
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (02) : 247 - 255
  • [49] Comparison of the modified geometric mean and buildup factor internal dosimetry techniques used for organ activity quantitation of 131I- and 90Y-labeled antibodies.
    Yeldell, D
    Mardirossian, G
    Sharkey, RM
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 22P - 22P
  • [50] ANTIBODY GUIDED IRRADIATION OF MALIGNANT PLEURAL AND PERICARDIAL-EFFUSIONS USING I-131 LABELED MONOCLONAL-ANTIBODIES HMFG2 AND AUA1
    HOOKER, G
    SNOOK, D
    COURTENAYLUCK, N
    DHOKIA, B
    ORR, JS
    DURBIN, H
    TAYLORPAPADIMITRIOU, J
    BODMER, WF
    EPENETOS, AA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (2-3): : A10 - A10
12345